In collaboration with our partner, Versant Physics, based in the US, we are excited to announce the upcoming launch of QDOSE+. This QDSOE+ platform represents a significant advancement in the field of dosimetry within Molecular Imaging and Radiotherapy. Our official unveiling will take place at the prestigious SNMMI meeting in Chicago.

At the heart of QDOSE+ lies a steadfast commitment to elevating the standard of precision patient care. This platform introduces an array of cutting-edge capabilities tailored to meet the demands of multi-radionuclide applications. Notably, QDOSE+ pioneers an innovative approach to theranostics, marking a significant stride towards a more integrated and comprehensive patient treatment paradigm.

We eagerly anticipate the opportunity to share the groundbreaking features and benefits of QDOSE+ with the industry’s leading experts and professionals at the SNMMI meeting. This launch represents a pivotal moment in the evolution of dosimetry, promising to reshape the landscape of Molecular Imaging and Radiotherapy for the better.